Clinical Trials in Rondebosch, South Africa
1 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Bristol-Myers Squibb76 enrolled48 locationsNCT06946797
Recruiting
Not Applicable
South Africa Smoking Cessation and Engagement in HIV/TB Care Care
HIV InfectionsSmoking CessationTuberculosis
Massachusetts General Hospital86 enrolled1 locationNCT05842161
Recruiting
Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Cancer
Bayer402 enrolled383 locationsNCT04464226